By having a European subsidiary, Medlab can save on drug registration fees.
() has formally incorporated a wholly owned subsidiary MDC Europe Limited to facilitate expansion into Europe.
The subsidiary will be used specifically for current and future dealings regarding NanaBis™ and the proposed drug registration models as per the European Medicines Agency (EMA).
NanaBis™ is one of two of Medlab’s cannabis-based medicines which contains formulations of tetrahydrocannabinol (THC) and cannabidiol (CBD).
European registration of NanaBis™ progressing
Meetings have been held with EMA on the pathway for registration of NanaBis™.